Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.42 |
| ▸ | ITGAV | P06756 | 14/20 | 0.42 |
| ▸ | ITGB1 | P05556 | 9/20 | 0.42 |
| ▸ | ITGA5 | P08648 | 9/20 | 0.42 |
| ▸ | ITGB6 | P18564 | 7/20 | 0.42 |
| ▸ | ITGB8 | P26012 | 7/20 | 0.42 |
| ▸ | ITGB5 | P18084 | 6/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14585783 | 0.86 | ITGB3 (0.49) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL8363710 | 0.81 | ITGB3 (0.45) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585796 | 0.81 | ITGB3 (0.49) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585791 | 0.79 | ITGB3 (0.38) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585782 | 0.77 | ITGB3 (0.43) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL8365684 | 0.76 | ITGB3 (0.41) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585813 | 0.76 | ITGB3 (0.41) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585789 | 0.75 | ITGB3 (0.47) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL8366299 | 0.74 | ITGB3 (0.44) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL14585785 | 0.73 | PLAU (0.42) | ITGB3ITGAVITGB1ITGA5ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179446-B2 | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-02-20 | — | — | US | disclosed |